"Andreas and Thomas Struengmann have collectively added about $8 billion to their wealth this year thanks to their stake in BioNTech SE, the German firm that's developing the vaccine with Pfizer. "
Read More
"Thomas Struengmann said in a December interview with German newspaper Handelsblatt that the brothers initially promised themselves they wouldn't invest more than 1 billion euros in the biotech sector because of the risks and requisite patience. "
Read More